shine-logo

SHINE Announces Chris Vessell as General Manager of Therapeutics Division

JANESVILLE, Wis., May 23, 2022 – SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, today announced Chris Vessell has joined as General Manager of the Therapeutics Division. In this role, he will be responsible for developing and building the team dedicated to SHINE’s strategy and offerings around non-carrier-added lutetium-177 for cancer therapies.

2022-05-23T14:37:54-05:00May 23, 2022|2022, News, News Releases, Therapeutics|

SHINE and Telix Pharmaceuticals Announce Lutetium-177 Clinical Supply Agreement

SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, and Telix Pharmaceuticals LTD (Telix), a biopharmaceutical company headquartered in Australia, today announced the signing of a clinical supply agreement that provides Telix with SHINE’s non-carrier-added (n.c.a.) lutetium-177 (Lu-177) for use in the clinical development of potential new therapeutics to treat prostate and kidney cancer.

2022-02-09T20:42:58-06:00February 10, 2022|2022, News, News Releases|

SHINE Europe B.V. Designing Advanced Medical Isotopes Facility in the Netherlands

A leader in nuclear technology obtains funding to produce medical isotopes in Europe and to help meet growing demands to provide diagnostic imaging for life-threatening diseases on a global scale.

2022-02-01T17:57:14-06:00February 2, 2022|2022, News, News Releases|

SHINE and Department of Energy Sign First-ever Contracts Under Uranium Lease and Take-back Program for Molybdenum-99

Vital medical radioisotope used in over 40,000 medical diagnostic procedures in the United States every day SHINE’s Mo-99 production facility steadily progressing construction in Janesville, Wis.Credit: SHINE Technologies LLC [...]

2022-03-09T09:23:37-06:00January 6, 2022|2022, News, News Releases|

SHINE’s new name highlights technology competencies and multiple phase opportunities

A test engineer works in SHINE's manufacturing facility in Fitchburg, Wis. JANESVILLE, Wis., Sept. 21, 2021 – SHINE Medical Technologies LLC today announced that the company has [...]

2021-12-17T17:23:41-06:00September 22, 2021|2021, News, News Releases|

SHINE commemorates completion of new corporate headquarters

SHINE Medical Technologies LLC today announced the completion of its new corporate headquarters. The company now has three facilities on its campus on U.S. Highway 51 across from the Southern Wisconsin Regional Airport.

2022-03-09T09:26:12-06:00August 6, 2021|2021, General, News, News Releases|

SHINE Medical Technologies Closes $150-million Series C-5 Financing

SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors.

2021-12-17T17:35:59-06:00June 28, 2021|2021, News, News Releases|
Go to Top